ID   SAE1_HUMAN              Reviewed;         346 AA.
AC   Q9UBE0; B2RDP5; B3KMQ2; F5GXX7; G3XAK6; O95717; Q9P020;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=SUMO-activating enzyme subunit 1;
DE   AltName: Full=Ubiquitin-like 1-activating enzyme E1A;
DE   Contains:
DE     RecName: Full=SUMO-activating enzyme subunit 1, N-terminally processed;
GN   Name=SAE1; Synonyms=AOS1, SUA1, UBLE1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DIMERIZATION, AND FUNCTION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=9920803; DOI=10.1006/bbrc.1998.9995;
RA   Okuma T., Honda R., Ichikawa G., Tsumagari N., Yasuda H.;
RT   "In vitro SUMO-1 modification requires two enzymatic steps, E1 and
RT   E2.";
RL   Biochem. Biophys. Res. Commun. 254:693-698(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DIMERIZATION, AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=10217437; DOI=10.1016/S0014-5793(99)00367-1;
RA   Gong L., Li B., Millas S., Yeh E.T.H.;
RT   "Molecular cloning and characterization of human AOS1 and UBA2,
RT   components of the sentrin-activating enzyme complex.";
RL   FEBS Lett. 448:185-189(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 1-11;
RP   109-117 AND 186-193, DIMERIZATION, AND FUNCTION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10187858; DOI=10.1074/jbc.274.15.10618;
RA   Desterro J.M.P., Rodriguez M.S., Kemp G.D., Hay R.T.;
RT   "Identification of the enzyme required for activation of the small
RT   ubiquitin-like protein SUMO-1.";
RL   J. Biol. Chem. 274:10618-10624(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=B-cell;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DIMERIZATION, AND FUNCTION.
RX   PubMed=11481243;
RA   Azuma Y., Tan S.-H., Cavenagh M.M., Ainsztein A.M., Saitoh H.,
RA   Dasso M.;
RT   "Expression and regulation of the mammalian SUMO-1 E1 enzyme.";
RL   FASEB J. 15:1825-1827(2001).
RN   [12]
RP   FUNCTION.
RX   PubMed=11451954; DOI=10.1074/jbc.M104214200;
RA   Tatham M.H., Jaffray E., Vaughan O.A., Desterro J.M.P., Botting C.H.,
RA   Naismith J.H., Hay R.T.;
RT   "Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein
RT   substrates by SAE1/SAE2 and Ubc9.";
RL   J. Biol. Chem. 276:35368-35374(2001).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16620772; DOI=10.1016/j.abb.2006.03.002;
RA   Li T., Santockyte R., Shen R.-F., Tekle E., Wang G., Yang D.C.H.,
RA   Chock P.B.;
RT   "A general approach for investigating enzymatic pathways and
RT   substrates for ubiquitin-like modifiers.";
RL   Arch. Biochem. Biophys. 453:70-74(2006).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND VAL-2, CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH UBA2; SUMO1 AND
RP   ATP, AND FUNCTION.
RX   PubMed=15660128; DOI=10.1038/sj.emboj.7600552;
RA   Lois L.M., Lima C.D.;
RT   "Structures of the SUMO E1 provide mechanistic insights into SUMO
RT   activation and E2 recruitment to E1.";
RL   EMBO J. 24:439-451(2005).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) IN COMPLEX WITH UBA2 AND SUMO1,
RP   FUNCTION, AND MUTAGENESIS OF ARG-21 AND 24-ARG--TRP-26.
RX   PubMed=20164921; DOI=10.1038/nature08765;
RA   Olsen S.K., Capili A.D., Lu X., Tan D.S., Lima C.D.;
RT   "Active site remodelling accompanies thioester bond formation in the
RT   SUMO E1.";
RL   Nature 463:906-912(2010).
CC   -!- FUNCTION: The heterodimer acts as an E1 ligase for SUMO1, SUMO2,
CC       SUMO3, and probably SUMO4. It mediates ATP-dependent activation of
CC       SUMO proteins followed by formation of a thioester bond between a
CC       SUMO protein and a conserved active site cysteine residue on
CC       UBA2/SAE2. {ECO:0000269|PubMed:10187858,
CC       ECO:0000269|PubMed:10217437, ECO:0000269|PubMed:11451954,
CC       ECO:0000269|PubMed:11481243, ECO:0000269|PubMed:15660128,
CC       ECO:0000269|PubMed:20164921, ECO:0000269|PubMed:9920803}.
CC   -!- PATHWAY: Protein modification; protein sumoylation.
CC   -!- SUBUNIT: Heterodimer of SAE1 and UBA2/SAE2. The heterodimer
CC       corresponds to the two domains that are encoded on a single
CC       polypeptide chain in ubiquitin-activating enzyme E1. Interacts
CC       with UBE2I. {ECO:0000269|PubMed:15660128,
CC       ECO:0000269|PubMed:20164921}.
CC   -!- INTERACTION:
CC       Q9UBT2:UBA2; NbExp=8; IntAct=EBI-743154, EBI-718569;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11481243}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UBE0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UBE0-2; Sequence=VSP_045373, VSP_045374;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9UBE0-3; Sequence=VSP_045372, VSP_045375;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expression level increases during S phase and
CC       drops in G2 phase (at protein level).
CC       {ECO:0000269|PubMed:11481243}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-activating E1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF090385; AAD12785.2; -; mRNA.
DR   EMBL; AF046025; AAD23902.2; -; mRNA.
DR   EMBL; AF110956; AAD24433.1; -; mRNA.
DR   EMBL; AF161489; AAF29104.1; -; mRNA.
DR   EMBL; AL560234; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BT007290; AAP35954.1; -; mRNA.
DR   EMBL; AK021978; BAG51064.1; -; mRNA.
DR   EMBL; AK315624; BAG37992.1; -; mRNA.
DR   EMBL; AC008532; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008755; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471126; EAW57461.1; -; Genomic_DNA.
DR   EMBL; CH471126; EAW57463.1; -; Genomic_DNA.
DR   EMBL; BC000344; AAH00344.1; -; mRNA.
DR   EMBL; BC003611; AAH03611.1; -; mRNA.
DR   EMBL; BC018271; AAH18271.1; -; mRNA.
DR   CCDS; CCDS12696.1; -. [Q9UBE0-1]
DR   CCDS; CCDS54284.1; -. [Q9UBE0-2]
DR   CCDS; CCDS54285.1; -. [Q9UBE0-3]
DR   RefSeq; NP_001139185.1; NM_001145713.1. [Q9UBE0-3]
DR   RefSeq; NP_001139186.1; NM_001145714.1. [Q9UBE0-2]
DR   RefSeq; NP_005491.1; NM_005500.2. [Q9UBE0-1]
DR   UniGene; Hs.515500; -.
DR   PDB; 1Y8Q; X-ray; 2.25 A; A/C=1-346.
DR   PDB; 1Y8R; X-ray; 2.75 A; A/D=1-346.
DR   PDB; 3KYC; X-ray; 2.45 A; A=1-346.
DR   PDB; 3KYD; X-ray; 2.61 A; A=1-346.
DR   PDBsum; 1Y8Q; -.
DR   PDBsum; 1Y8R; -.
DR   PDBsum; 3KYC; -.
DR   PDBsum; 3KYD; -.
DR   DisProt; DP00485; -.
DR   ProteinModelPortal; Q9UBE0; -.
DR   SMR; Q9UBE0; -.
DR   BioGrid; 115366; 55.
DR   DIP; DIP-34587N; -.
DR   IntAct; Q9UBE0; 21.
DR   MINT; MINT-1205002; -.
DR   STRING; 9606.ENSP00000270225; -.
DR   BindingDB; Q9UBE0; -.
DR   ChEMBL; CHEMBL1615388; -.
DR   iPTMnet; Q9UBE0; -.
DR   PhosphoSitePlus; Q9UBE0; -.
DR   SwissPalm; Q9UBE0; -.
DR   BioMuta; SAE1; -.
DR   DMDM; 42559897; -.
DR   EPD; Q9UBE0; -.
DR   MaxQB; Q9UBE0; -.
DR   PaxDb; Q9UBE0; -.
DR   PeptideAtlas; Q9UBE0; -.
DR   PRIDE; Q9UBE0; -.
DR   DNASU; 10055; -.
DR   Ensembl; ENST00000270225; ENSP00000270225; ENSG00000142230. [Q9UBE0-1]
DR   Ensembl; ENST00000392776; ENSP00000440818; ENSG00000142230. [Q9UBE0-2]
DR   Ensembl; ENST00000413379; ENSP00000416557; ENSG00000142230. [Q9UBE0-3]
DR   GeneID; 10055; -.
DR   KEGG; hsa:10055; -.
DR   UCSC; uc002pgc.4; human. [Q9UBE0-1]
DR   CTD; 10055; -.
DR   DisGeNET; 10055; -.
DR   GeneCards; SAE1; -.
DR   HGNC; HGNC:30660; SAE1.
DR   HPA; HPA041906; -.
DR   HPA; HPA043552; -.
DR   MalaCards; SAE1; -.
DR   MIM; 613294; gene.
DR   neXtProt; NX_Q9UBE0; -.
DR   OpenTargets; ENSG00000142230; -.
DR   PharmGKB; PA162402387; -.
DR   eggNOG; KOG2014; Eukaryota.
DR   eggNOG; COG0476; LUCA.
DR   GeneTree; ENSGT00550000075007; -.
DR   HOGENOM; HOG000172217; -.
DR   HOVERGEN; HBG080782; -.
DR   InParanoid; Q9UBE0; -.
DR   KO; K10684; -.
DR   OMA; SEMSPVC; -.
DR   OrthoDB; EOG091G0DZ1; -.
DR   PhylomeDB; Q9UBE0; -.
DR   TreeFam; TF315037; -.
DR   Reactome; R-HSA-3065676; SUMO is conjugated to E1 (UBA2:SAE1).
DR   Reactome; R-HSA-3065678; SUMO is transferred from E1 to E2 (UBE2I, UBC9).
DR   UniPathway; UPA00886; -.
DR   EvolutionaryTrace; Q9UBE0; -.
DR   GeneWiki; SAE1; -.
DR   GenomeRNAi; 10055; -.
DR   PRO; PR:Q9UBE0; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000142230; -.
DR   CleanEx; HS_SAE1; -.
DR   ExpressionAtlas; Q9UBE0; baseline and differential.
DR   Genevisible; Q9UBE0; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031510; C:SUMO activating enzyme complex; IDA:UniProtKB.
DR   GO; GO:0043008; F:ATP-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc.
DR   GO; GO:0008022; F:protein C-terminus binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:CAFA.
DR   GO; GO:0044388; F:small protein activating enzyme binding; IPI:CAFA.
DR   GO; GO:0004839; F:ubiquitin activating enzyme activity; TAS:UniProtKB.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016925; P:protein sumoylation; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:UniProtKB.
DR   InterPro; IPR000594; ThiF_NAD_FAD-bd.
DR   InterPro; IPR000011; UBQ/SUMO-activ_enz_E1-like.
DR   Pfam; PF00899; ThiF; 1.
DR   PRINTS; PR01849; UBIQUITINACT.
DR   SUPFAM; SSF69572; SSF69572; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Ligase; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation pathway.
FT   CHAIN         1    346       SUMO-activating enzyme subunit 1.
FT                                /FTId=PRO_0000194966.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:19413330}.
FT   CHAIN         2    346       SUMO-activating enzyme subunit 1, N-
FT                                terminally processed.
FT                                /FTId=PRO_0000423290.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES       2      2       N-acetylvaline; in SUMO-activating enzyme
FT                                subunit 1, N-terminally processed.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     198    198       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9R1T2}.
FT   VAR_SEQ     245    299       VLLKFRTDKGRDPSSDTYEEDSELLLQIRNDVLDSLGISPD
FT                                LLPEDFVRYCFSEM -> GPVSAGPSSQQLLLLRWHEGEWD
FT                                CGVPWPQVNSRFGSPRDANCSMPTCIPCPLPS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045372.
FT   VAR_SEQ     245    266       VLLKFRTDKGRDPSSDTYEEDS -> GTASPRWPQCVRWLE
FT                                GFWHRKL (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_045373.
FT   VAR_SEQ     267    346       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_045374.
FT   VAR_SEQ     300    346       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045375.
FT   MUTAGEN      21     21       R->A: Abolishes ATP-dependent activation
FT                                of SUMO proteins.
FT                                {ECO:0000269|PubMed:20164921}.
FT   MUTAGEN      24     26       RLW->AAA: Abolishes ATP-dependent
FT                                activation of SUMO proteins.
FT                                {ECO:0000269|PubMed:20164921}.
FT   CONFLICT    115    115       I -> M (in Ref. 6; BAG51064).
FT                                {ECO:0000305}.
FT   CONFLICT    158    158       V -> A (in Ref. 4; AAF29104).
FT                                {ECO:0000305}.
FT   CONFLICT    178    180       KTK -> ETD (in Ref. 4; AAF29104).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       Q -> H (in Ref. 4; AAF29104).
FT                                {ECO:0000305}.
FT   CONFLICT    273    273       R -> G (in Ref. 1; AAD12785).
FT                                {ECO:0000305}.
FT   HELIX        13     26       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX        28     35       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND       38     42       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX        46     58       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND       61     66       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND       73     75       {ECO:0000244|PDB:3KYC}.
FT   HELIX        76     78       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX        91    101       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      106    111       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       115    117       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       120    123       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      127    133       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       136    148       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      152    160       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      162    168       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      170    177       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      206    212       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       216    219       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       227    233       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       239    252       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      253    255       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       259    261       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       262    278       {ECO:0000244|PDB:1Y8Q}.
FT   TURN        279    281       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       284    286       {ECO:0000244|PDB:1Y8Q}.
FT   HELIX       289    293       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      296    298       {ECO:0000244|PDB:3KYC}.
FT   HELIX       300    319       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      327    332       {ECO:0000244|PDB:1Y8Q}.
FT   TURN        333    336       {ECO:0000244|PDB:1Y8Q}.
FT   STRAND      337    341       {ECO:0000244|PDB:1Y8Q}.
SQ   SEQUENCE   346 AA;  38450 MW;  E2B10A69FF2ED746 CRC64;
     MVEKEEAGGG ISEEEAAQYD RQIRLWGLEA QKRLRASRVL LVGLKGLGAE IAKNLILAGV
     KGLTMLDHEQ VTPEDPGAQF LIRTGSVGRN RAEASLERAQ NLNPMVDVKV DTEDIEKKPE
     SFFTQFDAVC LTCCSRDVIV KVDQICHKNS IKFFTGDVFG YHGYTFANLG EHEFVEEKTK
     VAKVSQGVED GPDTKRAKLD SSETTMVKKK VVFCPVKEAL EVDWSSEKAK AALKRTTSDY
     FLLQVLLKFR TDKGRDPSSD TYEEDSELLL QIRNDVLDSL GISPDLLPED FVRYCFSEMA
     PVCAVVGGIL AQEIVKALSQ RDPPHNNFFF FDGMKGNGIV ECLGPK
//
